Stockholders' Equity |
6 Months Ended |
|---|---|
Jun. 30, 2025 | |
| Stockholders' Equity | |
| Stockholders' Equity | 18.Stockholders’ Equity The Company has 50,000,000 authorized shares of capital stock, all of which are designated as common stock with par value of $0.001 per share. Each holder of shares of common stock is entitled to one vote for each share held. At-the-market offering On August 24, 2024, the Company’s registration statement on Form S-3 became effective, which allowed it to offer and sell securities from time to time in one or more offerings, up to an aggregate value of $150.0 million, including under its June 2024 Controlled Equity OfferingSM Sales Agreement with Cantor Fitzgerald & Co., pursuant to which the Company may offer and sell from time to time its common stock in an at-the-market (“ATM”) offering. Pursuant to this June 2024 agreement, the Company agreed to pay the sales agent commissions for their services in acting as agent with respect to the sale of shares through the ATM offering program. The sales commission and expenses related to the ATM equity offering program are considered direct and incremental costs and are charged against additional paid-in capital on the condensed consolidated balance sheet in the period in which the corresponding shares are issued and sold. As of June 30, 2025, the Company had issued and sold a total of 2,438,274 shares of its common stock for aggregate gross proceeds, net of sales commissions, of approximately $126,017 under the June 2024 sales agreement. On April 15, 2025, the Company entered into a Controlled Equity Offeringsm Sales Agreement with Barclays Capital Inc., Cantor Fitzgerald & Co., Canaccord Genuity LLC, Needham & Company, LLC, Craig-Hallum Capital Group LLC and Lake Street Capital Markets, LLC., pursuant to which the Company may offer and sell from time to time up to $500,000 of its common stock in an ATM offering. Pursuant to this April 2025 agreement, the Company agreed to pay the sales agents commissions for their services in acting as agent with respect to the sale of shares through the ATM offering program. The sales commission and expenses related to the ATM equity offering program are considered direct and incremental costs and are charged against additional paid-in capital on the condensed consolidated balance sheet in the period in which the corresponding shares are issued and sold. On April 22, 2025, the Company’s registration statement on Form S-3 for the sale of up to $500,000 in securities under this new sales agreement became effective and as of June 30, 2025, the Company had issued and sold a total of 3,816,449 shares of its common stock for aggregate gross proceeds, net of sales commissions, of approximately $146,483 under the $500.0 million ATM. |